Positive Topline Results for Novel Alzheimer’s Drug

Positive Topline Results for Novel Alzheimer’s Drug

A novel drug is showing promise for helping improve cognition in patients with mild to moderate Alzheimer's disease (AD), according to new topline results. A phase 3 trial of more than 800 patients showed that those who were... read more

Cognitive Function 3 and 12 Months After ICU Discharge

Cognitive Function 3 and 12 Months After ICU Discharge

In this prospective cohort study of Danish ICU patients, we found significantly reduced cognitive function for intensive care patients 3 and 12 months after discharge. We included 161 patients, 79 patients had a 3-month and... read more

My ICU Patient Lived. Is That Enough?

My ICU Patient Lived. Is That Enough?

As many as one in three patients sick enough to require a ventilator might develop symptoms of post-traumatic stress disorder. Anxiety and depression are equally common, if not more so. Others survive critical illness but... read more

Higher levels of tau protein found in children with early onset psychosis

Higher levels of tau protein found in children with early onset psychosis

New research shows that levels of a certain type of the Alzheimer's disease-related tau protein are higher in patients aged 18 years and under suffering early onset psychosis (EOP).... read more

Statins Associated with Reduced Alzheimer Risk

Statins Associated with Reduced Alzheimer Risk

An analysis of Medicare data suggests that high use of cholesterol-lowering statins was associated with a reduced risk of Alzheimer’s disease (AD), according to an article published online in JAMA Neurology. Previous research... read more